Two practices add peptide therapy in the same month. One is a med spa with a strong aesthetic patient base; the other is a functional medicine clinic running longitudinal metabolic care. A year later they look nothing alike, and both can be right.
The mistake is copying a program built for the other model.
The med spa starting point
A med spa arrives with real advantages: an existing patient base that already pays cash for elective care, a booking and rebooking habit, injection-comfortable staff, and a marketing engine that works.
The natural entry points are the ones adjacent to what the practice already sells — skin quality, hair, recovery, body composition — because the patient conversation is a small extension of one already happening in the chair.
The constraint is clinical infrastructure. Peptide therapy is longitudinal in a way that a filler appointment is not. It needs baseline labs and interval monitoring, a prescriber whose involvement is real rather than nominal, adverse-event pathways, and a plan for the patient whose metabolic screening comes back abnormal. Med spas that struggle usually struggle here, not on demand.
The functional medicine starting point
A functional medicine practice arrives with the opposite profile. Longitudinal care is already the model. Labs, monitoring, follow-up cadence and a patient who expects a plan rather than a procedure are all in place. Peptides slot into existing protocols instead of requiring new ones.
The constraint here is volume and pace. Functional medicine practices are often smaller, with longer visits and a slower path from interest to enrolment, and they are less likely to have a marketing engine that fills a new service line quickly. The program is clinically sound and commercially slow.
What actually differs
- Entry indication. Med spa: aesthetic and recovery-adjacent. Functional medicine: metabolic, longevity, gut, hormonal.
- Visit rhythm. Med spa: shorter, more frequent, procedure-anchored. Functional medicine: longer, structured around labs and review.
- Who prescribes. Med spa: often a medical director or collaborating prescriber whose involvement must be genuine and documented. Functional medicine: usually the treating clinician.
- Pricing shape. Med spa: packages that resemble existing treatment series. Functional medicine: programs and memberships tied to a care plan.
- Biggest risk. Med spa: clinical depth and supervision. Functional medicine: throughput and conversion.
What does not differ
The regulatory position is identical in both. A 503A pharmacy may only compound from an eligible substance regardless of your specialty. Medical necessity has to be documented either way. Informed consent for non-FDA-approved use is the same document. Advertising rules apply the same to both, and platform bans do not distinguish between a med spa and a clinic.
Nor does the sourcing question change. Whoever you are, a Certificate of Analysis that is not tied to your lot and produced by an independent laboratory tells you nothing.
Ready to put this into practice?
Explore Empire's hands-on, CME-accredited Practice Development & Business Strategies courses — live patients, expert faculty, and ongoing mentorship.
Choosing your first indication
Pick the one where your existing patients already have the problem, your staff already have the skill, and your clinical infrastructure already reaches. For most med spas that is a skin, hair or recovery indication. For most functional medicine practices it is metabolic or longevity.
Starting with the indication that is most exciting rather than most adjacent is the common failure. It requires new patients, new clinical capability and new monitoring all at once.
Frequently asked questions
How do I add peptide therapy to my practice?
Start from the indication closest to what you already treat, confirm the regulatory pathway for the specific substances, build the monitoring before the marketing, and price a course of care rather than a vial.
Can a med spa offer peptide therapy?
Where a prescriber is genuinely involved to the standard your state requires and the substances are lawfully obtainable. The supervision has to be real, not nominal.
Which is better for peptides, a med spa or a functional medicine practice?
Neither. They have different advantages and different failure modes; the program should be designed for the one you have.
Do I need new equipment?
Rarely. What is usually missing is clinical infrastructure — labs, monitoring cadence, adverse-event pathways — not hardware.
How do I start offering peptide therapy?
Start with the indication closest to what you already treat, so you are not building new demand, new clinical capability and new monitoring at once. Confirm the regulatory pathway for the specific substances before you build anything around them. Put the clinical infrastructure in place — baseline labs, monitoring cadence, adverse-event pathways — before the marketing. Then price a course of care rather than a vial.
Build it properly
The Empire Peptide Therapy Certification covers the clinical curriculum both models need, plus Module 11 on clinic economics and program design and Module 12 on the legal structure, taught with a healthcare law firm.
Related: 503A vs 503B compounding.
